Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Assessment of physiological barriers to nutrition following critical illness.
Clinical nutrition (Edinburgh, Scotland)·2021
Same author
Lumbar spondylolysis and spondylolisthesis.
JAAPA : official journal of the American Academy of Physician Assistants·2019
Same journal
The evolution of the PA profession in Switzerland.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal
Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal
Diabetic myonecrosis.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal
Acute coronary syndrome during active infusion of andexanet alfa.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal
Empowering PAs in health care: Unlocking the potential of implementation science.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal
The surgeon's tale.
JAAPA : official journal of the American Academy of Physician Assistants·2026
Related Experiment Video
Updated: Jan 31, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
1.9K
Updated guidelines for chronic obstructive pulmonary disease.
1Bethany Dunn is chair and program director of the PA program at D'Youville College in Buffalo, N.Y. The author has disclosed no potential conflicts of interest, financial or otherwise.
JAAPA : Official Journal of the American Academy of Physician Assistants
|December 28, 2018
Summary
The 2017 Global Initiative for Chronic Obstructive Lung Disease guidelines update COPD assessment and treatment. Key changes include revised evaluation tools, new medication strategies, and managing comorbidities for better chronic obstructive pulmonary disease care.
Area of Science:
- Pulmonology
- Clinical Practice Guidelines
Background:
- Chronic obstructive pulmonary disease (COPD) management requires updated clinical guidance.
- Previous guidelines may not reflect the latest evidence in COPD pharmacotherapy and assessment.
Purpose of the Study:
- To summarize the key revisions in the 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
- To highlight changes in COPD assessment, pharmacologic management, and non-pharmacologic treatments.
Main Methods:
- Review of the 2017 GOLD guidelines for chronic obstructive pulmonary disease.
- Analysis of updated recommendations on patient evaluation and treatment algorithms.
- Identification of new medication combinations and comorbidity management strategies.
Main Results:
- Introduction of a revised patient assessment tool for COPD.
- Implementation of a new pharmacologic algorithm for escalation and de-escalation of therapy.
- Recommendations for new combination inhaled medications and management of comorbidities.
Conclusions:
- The 2017 GOLD guidelines introduce significant updates to COPD evaluation and management.
- Clinicians should adopt the revised assessment tools and pharmacologic strategies.
- Integrated management of comorbidities is crucial for effective COPD care.